Data / Drug companies / Genomma Lab USA
Genomma Lab USA: 45 products in the FDA NDC directory, labeler code 50066
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Genomma Lab USA (labeler code 50066) lists 45 products in the FDA National Drug Code Directory, covering 17 finished drugs by generic name. By type: 45 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on September 15, 2026.
The request: Watch Genomma Lab USA (FDA labeler code 50066): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 50066
- Products in commercial distribution
- 45
- Packages
- 48
- Finished drugs by generic name
- 17
- Prescription products
- 0
- Over the counter products
- 45
- Flagged as original packager
- 43 of 43 products that carry the flag
- Started marketing in the last 12 months
- 6
- Products with a marketing end date set
- 1
- Earliest marketing start
- March 2, 2005
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 42 | 93.3% |
| Generic drugs (ANDA) | 3 | 6.7% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 45 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Salicylic acid | 9 | 330 |
| Miconazole nitrate | 2 | 101 |
| Terbinafine hydrochloride | 2 | 39 |
| Acetaminophen, aspirin, and caffeine | 1 | 13 |
| Menthol | 1 | 263 |
| Avobenzone, homosalate, octisalate, octocrylene | 1 | 157 |
| Dextromethorphan hydrobromide and guaifenesin | 1 | 16 |
| Acetaminophen | 1 | 214 |
| Dextromethorphan hbr, guaifenesin, phenylephrine hcl | 1 | 28 |
| Oxymetazoline hydrochloride | 1 | 64 |
| Aspirin | 1 | 134 |
| Coal tar | 1 | 22 |
| Menthol, (plus)-, camphor, (-)-, and methyl salicylate | 1 | 1 |
| Camphor, menthol, and methyl salicylate | 1 | 4 |
| Tolnaftate | 1 | 99 |
| Avobenzone, octocrylene, oxybenzone | 1 | 3 |
| Lidocaine hydrochloride | 1 | 134 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Liquid | 12 | 26.7% |
| Cream | 11 | 24.4% |
| Syrup | 9 | 20% |
| Soap | 6 | 13.3% |
| Tablet | 1 | 2.2% |
| Gel | 1 | 2.2% |
| Lotion | 1 | 2.2% |
| Tablet, coated | 1 | 2.2% |
| Aerosol, spray | 1 | 2.2% |
| Ointment | 1 | 2.2% |
| Kit | 1 | 2.2% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Dragon Lidocaine Pain | 50066-623 | Cream | Over the counter monograph drugs | September 15, 2026 |
| Tukol Max Action Cold and Flu Nighttime Relief | 50066-520 | Syrup | Over the counter monograph drugs | July 30, 2026 |
| Tio Nacho Anti-Dandruff | 50066-059 | Liquid | Over the counter monograph drugs | March 27, 2026 |
| BioElectro Extra Strength Headache Relief | 50066-630 | Tablet | Over the counter monograph drugs | December 26, 2025 |
| Asepxia Baking Soda Acne Bar | 50066-810 | Soap | Over the counter monograph drugs | November 25, 2025 |
| Medicasp Anti-Dandruff | 50066-040 | Liquid | Over the counter monograph drugs | November 25, 2025 |
| Silka Antifungal | 50066-085 | Liquid | Over the counter monograph drugs | September 30, 2025 |
| Nikzon Hemorrhoidal | 50066-010 | Cream | Over the counter monograph drugs | July 7, 2025 |
| Pomada Dragon Pain Relief | 50066-622 | Cream | Over the counter monograph drugs | February 14, 2025 |
| Tukol Max Action | 50066-518 | Liquid | Over the counter monograph drugs | February 12, 2025 |
| Silka Athletes Foot | 50066-084 | Aerosol, spray | Over the counter monograph drugs | February 3, 2025 |
| Cicatricure Gold Lift SPF 30 Sunscreen | 50066-181 | Lotion | Over the counter monograph drugs | December 27, 2024 |
| Asepxia Acne Treatment | 50066-064 | Cream | Over the counter monograph drugs | September 5, 2024 |
| Tukol Max Action Cold, Flu and Sore Throat | 50066-313 | Syrup | Over the counter monograph drugs | June 21, 2024 |
| Asepxia Acne | 50066-063 | Liquid | Over the counter monograph drugs | June 21, 2024 |
| Tukol Sugar Free Cough and Cold | 50066-505 | Syrup | Over the counter monograph drugs | June 13, 2024 |
| XRay Pain Relief | 50066-456 | Cream | Over the counter monograph drugs | December 26, 2023 |
| Triple antibiotic plus pain relief | 50066-202 | Ointment | Over the counter monograph drugs | December 21, 2023 |
| Tukol Honey Daytime and Nighttime Value Pack | 50066-304 | Kit | Over the counter monograph drugs | January 30, 2023 |
| XRay DOL | 50066-454 | Cream | Over the counter monograph drugs | June 2, 2022 |
| Tukol Children Cough and Congestion | 50066-308 | Syrup | Over the counter monograph drugs | June 1, 2022 |
| Bufferin Regular Strength Pain Relief | 50066-610 | Tablet, coated | Over the counter monograph drugs | May 17, 2021 |
| Dragon with Arnical Pain Relief | 50066-621 | Gel | Over the counter monograph drugs | November 23, 2020 |
| Tukol Cough and Congestion | 50066-510 | Syrup | Over the counter monograph drugs | June 7, 2020 |
| Asepxia Softening Acne Bar | 50066-805 | Soap | Over the counter monograph drugs | March 19, 2020 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.